OHE CONSULTING - Key Persons


Adrian Towse

Job Titles:
  • Director Emeritus
  • Member of the Research Committee
  • Senior Research Fellow
Adrian's current research includes incentives for new drugs and vaccines to tackle Antimicrobial Resistance, the use of 'risk-sharing' arrangements between health care payers and pharmaceutical companies, including value-based pricing approaches; the economics of pharmacogenetics for health care payers and the pharmaceutical industry; economic issues that affect both R&D for and access to treatments for diseases prevalent in the developing world. Cole, A. and Towse, A., 2018. Legal Barriers to Better the Better Use of Health Data to Deliver Pharmaceutical Innovation. OHE Consulting Report. Available at: https://www.ohe.org/publications/legal-barriers-better-use-health-data-deliver-pharmaceutical-innovation Professor Adrian Towse is Director Emeritus of the Office of Health Economics in the UK. Adrian's current research includes incentives for new drugs and vaccines to tackle Antimicrobial Resistance, the use of 'risk-sharing' arrangements between health care payers and pharmaceutical companies, including value-based pricing approaches; the economics of precision or stratified medicine for health care payers and the pharmaceutical industry; and economic issues that affect both R&D for and access to treatments for diseases prevalent in low and middle income countries. A Senior Visiting Fellow at the Health Economics Research Centre, Nuffield Department of Population Health, at the University of Oxford, Adrian also has been a Visiting Professor at the London School of Economics and a Visiting Professor at the University of York. For ten years, he served as a Non-Executive Director of the Oxford University Hospitals NHS Trust, one of the UK's largest hospital groups. Adrian was President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) for the 2014-15 term. Adrian joined the OHE in 1993 and served as Director for 25 years. He holds an MA (Hons) in Politics, Philosophy and Economics from Keble College, Oxford; an MPhil in Management Studies from Nuffield College, Oxford, and the Oxford Centre for Management Studies; and is a Member of the Chartered Institute of Management Accountants. Danzon, P.; Towse, A.; Mestre-Ferrandiz, J., 2015. Value-based differential pricing: efficient prices for drugs in a global context. Health Economics Volume. DOI: 10.1002/hec.3021

Charlotte Ashton

Job Titles:
  • Director of External Affairs
  • Member of the Research Committee
Charlotte has over a decade of experience in communications and external affairs for global NGO's and academia with a specialist focus on health and development. She is interested in maximising the impact of health economic research and health technology assessment (HTA) to build alliances to create a thriving ecosystem benefiting patients, the NHS, industry and the economy. She is currently focused on building strategic relationships across the sector to improve the UK's ability to generate, attract and benefit from biomedical innovation.

Charlotte Davies

Job Titles:
  • Member of the Research Committee
  • Head of OHE Academy
Charlotte joined OHE at the end of 2018 to take up the new role of Project Manager. Her role involves the planning and smooth execution of OHE research projects as well as supporting the overall growth of OHE. Before joining OHE Charlotte worked at the ICAEW and IoD as a Project / Programme Manager in Learning and Development, Sponsorship and Marketing teams.

Chris Sampson

Job Titles:
  • Member of the Research Committee
  • Principal Economist
Chris's primary research interest is economic evaluation in health care, including the development of new methods for cost-effectiveness analysis and the valuation of health. He has worked on trial- and model-based economic evaluations in a variety of clinical fields. Chris is also dedicated to building new platforms for collaboration in the discipline of health economics. Morriss, R., Garland, A., Nixon, N., Guo, B., James, M., Kaylor-Hughes, C., Moore, R., Ramana, R., Sampson, C.J., Sweeney, T., Dalgleish, T. and the NIHR CLAHRC Specialist Mood Disorder Study Group. (2016) Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial. The Lancet Psychiatry 3(9), 821-831. DOI: 10.1016/S2215-0366(16)30143-2

Chris Skedgel

Job Titles:
  • Director
  • Member of the Research Committee
Chris has over 20 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value of scarce healthcare resources, including the use of cost-effectiveness and cost-utility frameworks to evaluate value-for-money and stated preference methods to elicit patient and public values. He has more than 50 peer-reviewed publications on topics including cost-effectiveness evaluations, preference studies, methodological contributions and invited editorials. He sits on the editorial board of Pharmacoeconomics and is an Honorary Research Fellow with the Health Economics Group at the University of East Anglia, UK. He has been a Lead Economic Reviewer for the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Common Drug Review (CDR). Chris has a PhD in Health Economics & Decision Science from The University of Sheffield and a master's degree in Development Economics from Dalhousie University, Canada.

Claire Green - CEO

Job Titles:
  • Chief Executive
  • Member of the Research Committee
  • Personal Assistant
  • Personal Assistant to the Chief Executive
Claire Green is the Personal Assistant to the Chief Executive. A key aspect of her role is to provide time management and administrative support. Claire joined the OHE in January 2008 from Halcrow Group Limited she provided PA support to the Regional Managing Director. Claire has a degree in Psychology.

David Mott

Job Titles:
  • Member of the Research Committee
  • Senior Principal Economist
David's research interests broadly focus on the valuation of healthcare benefits. This includes describing health and valuing health states for the generation of quality-adjusted life years (QALYs) as well as the valuation and incorporation of broader outcomes (e.g. non-health outcomes or well-being) into the health technology assessment process.

Dimitrios Kourouklis

Job Titles:
  • Member of the Research Committee
  • Senior Economist
Dimitrios' research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D, where he applies econometric methods to examine questions related to incentives for innovation. In addition, he is interested in topics at the intersection of health and applied economics. Before joining OHE in 2020, Dimitrios worked as a Postdoctoral Researcher at the University of Bordeaux and also at the Centre for Industrial Economics of MINES ParisTech, where he continues to be affiliated as a Research Associate. Moreover, he has worked as a teaching and research assistant at the Frankfurt School of Finance & Management and the London School of Economics (LSE), respectively. Dimitrios holds a PhD in Economics from the Frankfurt School of Finance & Management, where he examined the effect of pharmaceutical expenditures and public subsidies on different types and stages of innovation in pharmaceuticals. He also holds a MSc in International Health Policy from the London School of Economics (LSE), a MSc in Economics from Athens University of Economics and Business and a BSc in Statistics and Insurance Science from the University of Piraeus.

Dr. Amanda Cole

Job Titles:
  • Member of the Policy Committee
  • Senior Principal Economist
Amanda's current research interests include the use of real world evidence to support HTA and product development; novel pricing and reimbursement mechanisms for pharmaceuticals (e.g. managed entry agreements and the economics of indication-based pricing); health state valuation methodology; criteria for the economic evaluation of health interventions; and the interaction between HTA policy and optimal R&D decisions by industry

Dr. Chris Henshall

Job Titles:
  • Member of the Policy Committee

Dr. Jamie Munro

Job Titles:
  • Member of the Policy Committee

Edward Oliver

Job Titles:
  • Member of the Research Committee
  • Economist
Edward joins the OHE team in September 2021 after completing an MSc in Health Economics at City University. He has a strong scientific background having studied Medical Physiology and Therapeutics at the undergraduate level. He also has over two and a half years experience in the Life Sciences industry working with private and public clients to develop health communication strategies. His MSc dissertation studies how public policy can be used to incentivise private firms to develop innovative products and drive R&D intensity.

Eleanor Bell

Job Titles:
  • Member of the Research Committee
  • Senior Economist
Eleanor joined the OHE in 2019 from studying at UCL, where she received the highest overall grade and highest dissertation mark of any masters level student in 2019 for her MSc in Health Economics and Decision Science. She also holds a Graduate Diploma in Economics from the University of Cambridge, and an undergraduate degree in History from the University of Oxford. She has five years of experience as a researcher and consultant working on a range of social development issues in low-income settings, including two years based in Freetown, Sierra Leone. Eleanor's research interests are the economics of health systems, health behaviour decision making, and the evaluation of healthcare programmes' effectiveness. She has a particular interest in health systems and public health interventions in low-income settings. Her masters thesis explored the relationship between income shocks, risky sexual behaviour and HIV rates in Malawi.

Elliot Dunster

Job Titles:
  • Member of the Policy Committee

Gayathri Kumar

Job Titles:
  • Member of the Research Committee
  • Senior Economist
Gayathri joined OHE in 2020. She has had 7 years of industry experience in health technology assessment and market access. She holds an MSc in Economic Evaluation in Healthcare from City University, London and a BA in Economics from the University of Cambridge.

Grace Hampson

Job Titles:
  • Associate Director
  • Member of the Research Committee
  • Visiting Research Associate
Grace's areas of expertise include health technology appraisal, economic modelling and clinical guidelines. Grace is also interested in the economic evaluation of diagnostics and patient stratification, early stage modelling, and the economic evaluation of regenerative medicines and other high cost therapies. Grace has recently been appointed to NICE's Clinical Guidelines Update Standing Committee, where she provides expert advice on the economic implications of NICE's clinical guideline recommendations. Grace is a Visiting Research Associate in the Science Policy Research Unit (SPRU) at the University of Sussex, and is an Expert Adviser for NICE's Centre for Guidelines.

Hannah Schirrmacher

Job Titles:
  • Member of the Research Committee
Hannah joined OHE in September 2020 as an OHE Fellow after completing a MSc in Development Economics at the University of Sussex. Her dissertation focused on investigating the effect of different government responses on COVID-19 deaths. Hannah has previously obtained a BSc in Economics from the University of Exeter and is currently undertaking an MSc in Health Economics at City, University of London. She gained exposure to research and public policy through a summer internship at the Institute of Economic Affairs.

Isobel Firth

Job Titles:
  • Member of the Research Committee
  • Senior Economist
Isobel joined OHE in 2020. She has an undergraduate degree in Natural Sciences specialising in infectious diseases from the University of Cambridge and a Masters of Public Health (MPH) from Imperial College London. Her MPH research focussed on inequality in pharmaceutical innovation for infectious diseases and the impact of World Bank income classification on pharmaceutical innovation. She has completed internships at the World Health Organisation and Drugs for Neglected Diseases Initiative (DNDi) in Geneva where she worked on their Paediatric HIV and Hepatitis C programmes.

Jake Hitch

Job Titles:
  • Member of the Research Committee
  • Economist
Jake joined OHE in June 2021 from the investment data and technology industry. Since joining, he has developed expertise in the economics of pharmaceutical innovation, quantitative patient preference research, and the effects of the COVID-19 pandemic on cancer services in the UK. Jake is also interested in economic epidemiology and healthcare systems in lower- and middle-income countries. Jake holds two economics degrees from the University of Bristol: MRes Economics (distinction) and BSc Economics (first-class honours). For his master's dissertation he investigated the extent to which mobile payment systems are helping households in rural Tanzania maintain food consumption, diet diversity, and livestock holdings in the aftermath of floods and drought. In addition to experience in investment research, Jake has worked as an online economics tutor.

Jia Pan

Job Titles:
  • Member of the Research Committee
Jia joined OHE in September 2020 as an OHE Fellow. She has a BSc in Economics from the University of Bristol and is undertaking an MSc in Health Economics at City University of London. Jia has previous experience within the healthcare management consulting industry and has worked for the NHS and pharmaceutical firms on product deployment and electronic health record (EHR) implementation projects.

Julie Ratcliffe

Job Titles:
  • Health Economics and Matthew Flinders Fellow, College of Nursing and Health Sciences

Kerry Sheppard

Job Titles:
  • Member of the Research Committee
  • Business Executive
Kerry's responsibilities include maintaining the website, overseeing the production and publishing of in-house publications, organising events and serving as the contact point for accounts. Before joining the OHE in 2000, she was with the ABPI.

Leia Davies

Job Titles:
  • Member of the Research Committee
  • Team Assistant
Leia Davies joined the OHE in December 2019 and provides administrative and logistical support to the team. Leia has previously worked for Royal Mail and MCA in administrative roles and has a background in the arts and events. Leia studied Philosophy and Fine Art and exhibits her artwork in her spare time.

Margherita Neri

Job Titles:
  • Member of the Research Committee
  • Principal Economist
Margherita joined the OHE in December 2016 as Economist. Her work at the OHE has involved a number consulting projects, relating to different aspects of pharmaceutical R&D and HTA activities. She has experience in supporting the development of internal strategies for pharmaceutical companies in defining the value proposition of their pipeline (e.g. value frameworks) and the evidence generation processes during the product lifecycle.

Mikel Berdud

Job Titles:
  • Member of the Research Committee
  • Senior Principal Economist
Mikel's current research interests are the economics of the pharmaceutical industry; including innovation and incentives for encouraging medical R&D, regulation of pharmaceutical markets and social welfare analysis, and competition and incentives for health care providers.

Nadine Henderson

Job Titles:
  • Senior Economist
Nadine joined the OHE in October 2019 upon completing her MSc in Health Economics at the University of York. She conducted her dissertation research during a 3-month placement at the University of Technology Sydney; assessing whether the newly developed multi-attribute utility instrument EORTC QLU-C10D, is appropriate for use in primary brain cancer patients given the exclusion of a cognitive functioning scale.

Patricia Cubi-Molla

Job Titles:
  • Senior Principal Economist
Patricia's main areas of research are: health-related quality of life measures, subjective well-being, cost-effectiveness thresholds, estimation of health-related outcomes, health policy evaluation, adaptation to health states, ordered choice models and theory of preferences.

Phill O'Neill

Job Titles:
  • Head of Information and Analysis
Phill's research interests include the economics of the pharmaceutical market, the productivity and outputs of NICE, and benchmarking industry performance. He has extensive knowledge of, and experience with, data and other information used to understand the medicines market and performance of the pharmaceutical industry.

Priscila Radu

Priscila joined OHE is September 2021 as an OHE Fellow. She is currently studying an MSc in Economic Evaluation in Healthcare at City University London. Priscila was previously an associate at a healthcare communication firm, providing support for clients from all sub-sectors of healthcare. Priscila holds a BSc in Biomedical Sciences from King's College London, and has spent a year at the University of North Carolina at Chapel Hill as part of her degree.

Prof. Anita Charlesworth

Job Titles:
  • Chairman of the Policy Committee
  • Member of the Research Committee

Prof. Graham Cookson - CEO

Job Titles:
  • Chief Executive
  • Member of the Policy Committee
  • Member of the Research Committee
  • Chief Executive of the Office of Health Economics
Professor Graham Cookson is the Chief Executive of the Office of Health Economics, taking over from Professor Adrian Towse who led OHE for 25 years.

Prof. Hugh Gravelle

Job Titles:
  • Member of the Research Committee

Prof. John Brazier

Job Titles:
  • Member of the Research Committee

Prof. Lotte Steuten

Job Titles:
  • Deputy Chief Executive
  • Member of the Policy Committee
  • Member of the Research Committee
  • Head of Consulting and Vice President of the Office of Health Economics
Professor Lotte Steuten is Head of Consulting and Vice President of the Office of Health Economics. Lotte's research interest focuses on the development and application of health economic analysis and health technology assessment (HTA), with the aim to accelerate patient access to high value health care services and treatments. She specializes in quantitative methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in disease prevention, diagnostics and treatment, and prioritizing data collection to efficiently build the evidence for new interventions. After obtaining her PhD she has acquired >10 years of international expertise in leading health economics and HTA projects to inform a wide range of decision problems, working effectively with various academic and non-academic stakeholders including patients, care providers, payers, policy makers, innovators and manufacturers. Prior to joining OHE, Lotte was an associate member at the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Research Center, and an affiliate associate professor in the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle. She co-founded Panaxea bv, a health innovation consultancy firm with offices in the Netherlands, Belgium and Germany, and served as its Chief Executive and Scientific Officer for nearly 10 years. Previously, Lotte has worked as (senior) investigator at well-known health economic departments of universities in the UK (Health Economics Research Group, Brunel University, London) and the Netherlands (Twente University and Maastricht University) where she conducted numerous studies varying from the early assessment of specialized medical technologies to full economic evaluation of chronic care programs. In various roles she was responsible for developing, leading and conducting health economic research programs and was director of a health sciences graduate education program. Lotte serves on the ISPOR Value of Information TaskForce and on the editorial board of various academic journals. She has an MSc and PhD (cum laude) from Maastricht University, the Netherlands and is currently an Honorary Professor at City University, London as of 1 April 2019. Lotte has published nearly 100 original peer reviewed journal articles and is the editor of a textbook on the Economics of Personalized Medicine (forthcoming in 2019). She is a frequent presenter and panelist at conferences on health innovation and economics worldwide.

Prof. Margaret Kyle

Job Titles:
  • Chairman of the Research Committee

Prof. Mike Drummond

Job Titles:
  • Member of the Research Committee

Prof. Mireia Jofre-Bonet

Job Titles:
  • Chief Research Officer
  • Head of Education
  • Member of the Policy Committee
  • Member of the Research Committee
  • Economist
  • Head of Research and Vice President of the Office of Health Economics
Mireia Jofre-Bonet is Head of Research and Vice President of the Office of Health Economics, replacing Professor Nancy Devlin. Mireia is an economist specialised in health economics. She has worked on a broad spectrum of Health Economics subjects including Lifestyle and Health Behaviour Decision Making; topics in Industrial Organisation applied to the Health Care sector and Pharmaceutical Regulation; Willingness To Pay for Health Insurance Schemes by the informal sector in low and middle income countries; Environmental factors and children's health and wellbeing (domestic violence, maternal working hours; intergenerational transmission of health & behaviours); Adaptation to Health States; and, Migration and adaptation. Mireia joined OHE on 23 April 2019 and remains associated to the Department of Economics and the City Health Economics Centre at City, University of London, where she has been Professor in Economics and Deputy Head of the Department, and the Director of the MSc in Health Economics and the MSc in Economic Evaluation in Healthcare for more than a decade. Prior to joining City, Professor Jofre-Bonet was a Lecturer at LSHTM, a Research Faculty member at the School of Public Health at Yale University, and taught at the Departments of Economics at the London School of Economics and at Yale University. Mireia is a Senior Associated Researcher at LSE Health Policy (London School of Economics and Political Sciences), collaborates with the London School of Hygiene and Tropical Medicine, belongs to the London International Development Centre, and is an Expert Advisor for the NICE Centre for Guidelines and the ESRC Peer Review College. She has been a Core Member of NICE Public Health Committee and has contributed to health economics projects and reviews public institutions -including the UK Department of Health, the NIHR Health Technology Assessment programme, the Sierra Leone National Social Insurance Trust and the Catalan and the Balearic Island's Departments of Health. Mireia is a member of the Health Economics Study Group and AES (Asociación Economía Salud, Spain).

Prof. Patricia Danzon

Job Titles:
  • Member of the Research Committee

Prof. Rafael Bengoa

Job Titles:
  • Member of the Policy Committee

Prof. Tony Culyer

Job Titles:
  • Member of the Research Committee

Sian Besley

Job Titles:
  • Economist
Sian joined OHE in September 2021 following the completion of her Masters in Health Economics at the University of York. Her dissertation was undertaken with supervision from the Centre for Health Economics (York) and focused on exploring the relationship between distance and A&E department demand. Prior to her Masters, Sian obtained a BSc in Economics from Newcastle University. As part of her undergraduate studies, she engaged in a 13-month placement as a Research Assistant at the Bank of England.

Simon Brassel

Job Titles:
  • Principal Economist
Simon started working at the OHE in 2019 after completing (with Distinction) a MSc in Health Policy (Health Economics) from the London School of Economics and Political Sciences (LSE) in 2018.

Siva Anandaciva

Job Titles:
  • Member of the Policy Committee